nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Methoxsalen—psoriasis	0.165	0.23	CbGbCtD
Letrozole—CYP19A1—Betamethasone—psoriasis	0.129	0.179	CbGbCtD
Letrozole—CYP2A6—Prednisolone—psoriasis	0.0803	0.112	CbGbCtD
Letrozole—CYP19A1—Dexamethasone—psoriasis	0.0748	0.104	CbGbCtD
Letrozole—CYP2A6—Dexamethasone—psoriasis	0.0474	0.0659	CbGbCtD
Letrozole—CYP3A4—Calcitriol—psoriasis	0.0425	0.0592	CbGbCtD
Letrozole—CYP3A4—Methoxsalen—psoriasis	0.033	0.046	CbGbCtD
Letrozole—CYP3A4—Cholecalciferol—psoriasis	0.0219	0.0305	CbGbCtD
Letrozole—CYP3A4—Mycophenolate mofetil—psoriasis	0.019	0.0264	CbGbCtD
Letrozole—CYP3A4—Triamcinolone—psoriasis	0.019	0.0264	CbGbCtD
Letrozole—CYP3A4—Betamethasone—psoriasis	0.0163	0.0227	CbGbCtD
Letrozole—CYP3A4—Prednisolone—psoriasis	0.0161	0.0224	CbGbCtD
Letrozole—CYP3A4—Hydrocortisone—psoriasis	0.0152	0.0212	CbGbCtD
Letrozole—CYP3A4—Prednisone—psoriasis	0.0152	0.0211	CbGbCtD
Letrozole—CYP3A4—Cyclosporine—psoriasis	0.0144	0.02	CbGbCtD
Letrozole—CYP3A4—Dexamethasone—psoriasis	0.00947	0.0132	CbGbCtD
Letrozole—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.000158	0.177	CbGpPWpGaD
Letrozole—Alopecia—Prednisone—psoriasis	0.000123	0.000437	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—psoriasis	0.000122	0.000435	CcSEcCtD
Letrozole—Gastrointestinal pain—Cyclosporine—psoriasis	0.000122	0.000434	CcSEcCtD
Letrozole—Dizziness—Mycophenolic acid—psoriasis	0.000122	0.000434	CcSEcCtD
Letrozole—Paraesthesia—Prednisolone—psoriasis	0.000122	0.000434	CcSEcCtD
Letrozole—Tachycardia—Triamcinolone—psoriasis	0.000122	0.000434	CcSEcCtD
Letrozole—Mental disorder—Prednisone—psoriasis	0.000122	0.000433	CcSEcCtD
Letrozole—Malnutrition—Prednisone—psoriasis	0.000121	0.00043	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000121	0.00043	CcSEcCtD
Letrozole—Hyperhidrosis—Triamcinolone—psoriasis	0.000121	0.000429	CcSEcCtD
Letrozole—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00012	0.000427	CcSEcCtD
Letrozole—Insomnia—Hydrocortisone—psoriasis	0.00012	0.000427	CcSEcCtD
Letrozole—Hypertension—Dexamethasone—psoriasis	0.00012	0.000426	CcSEcCtD
Letrozole—Hypertension—Betamethasone—psoriasis	0.00012	0.000426	CcSEcCtD
Letrozole—Paraesthesia—Hydrocortisone—psoriasis	0.000119	0.000424	CcSEcCtD
Letrozole—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000119	0.000423	CcSEcCtD
Letrozole—Urticaria—Cyclosporine—psoriasis	0.000118	0.000422	CcSEcCtD
Letrozole—Myalgia—Betamethasone—psoriasis	0.000118	0.00042	CcSEcCtD
Letrozole—Myalgia—Dexamethasone—psoriasis	0.000118	0.00042	CcSEcCtD
Letrozole—Abdominal pain—Cyclosporine—psoriasis	0.000118	0.00042	CcSEcCtD
Letrozole—Body temperature increased—Cyclosporine—psoriasis	0.000118	0.00042	CcSEcCtD
Letrozole—Anxiety—Betamethasone—psoriasis	0.000118	0.000419	CcSEcCtD
Letrozole—Anxiety—Dexamethasone—psoriasis	0.000118	0.000419	CcSEcCtD
Letrozole—Vomiting—Mycophenolic acid—psoriasis	0.000117	0.000417	CcSEcCtD
Letrozole—Discomfort—Dexamethasone—psoriasis	0.000117	0.000415	CcSEcCtD
Letrozole—Discomfort—Betamethasone—psoriasis	0.000117	0.000415	CcSEcCtD
Letrozole—Dyspepsia—Hydrocortisone—psoriasis	0.000117	0.000415	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—psoriasis	0.000117	0.000415	CcSEcCtD
Letrozole—Rash—Mycophenolic acid—psoriasis	0.000116	0.000414	CcSEcCtD
Letrozole—Dermatitis—Mycophenolic acid—psoriasis	0.000116	0.000413	CcSEcCtD
Letrozole—Pain—Prednisolone—psoriasis	0.000116	0.000413	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—psoriasis	0.000116	0.000413	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—psoriasis	0.000116	0.000413	CcSEcCtD
Letrozole—Urticaria—Mycophenolate mofetil—psoriasis	0.000116	0.000411	CcSEcCtD
Letrozole—Headache—Mycophenolic acid—psoriasis	0.000115	0.000411	CcSEcCtD
Letrozole—Decreased appetite—Hydrocortisone—psoriasis	0.000115	0.00041	CcSEcCtD
Letrozole—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000115	0.000409	CcSEcCtD
Letrozole—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000115	0.000409	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—psoriasis	0.000115	0.000408	CcSEcCtD
Letrozole—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000114	0.000407	CcSEcCtD
Letrozole—Fatigue—Hydrocortisone—psoriasis	0.000114	0.000407	CcSEcCtD
Letrozole—Vision blurred—Prednisone—psoriasis	0.000114	0.000405	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—psoriasis	0.000114	0.000405	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000114	0.000405	CcSEcCtD
Letrozole—Pain—Hydrocortisone—psoriasis	0.000113	0.000403	CcSEcCtD
Letrozole—Oedema—Dexamethasone—psoriasis	0.000113	0.000403	CcSEcCtD
Letrozole—Anaphylactic shock—Dexamethasone—psoriasis	0.000113	0.000403	CcSEcCtD
Letrozole—Anaphylactic shock—Betamethasone—psoriasis	0.000113	0.000403	CcSEcCtD
Letrozole—Oedema—Betamethasone—psoriasis	0.000113	0.000403	CcSEcCtD
Letrozole—Insomnia—Triamcinolone—psoriasis	0.000113	0.000402	CcSEcCtD
Letrozole—Infection—Dexamethasone—psoriasis	0.000112	0.0004	CcSEcCtD
Letrozole—Infection—Betamethasone—psoriasis	0.000112	0.0004	CcSEcCtD
Letrozole—Ill-defined disorder—Prednisone—psoriasis	0.000112	0.000399	CcSEcCtD
Letrozole—Paraesthesia—Triamcinolone—psoriasis	0.000112	0.000399	CcSEcCtD
Letrozole—Feeling abnormal—Prednisolone—psoriasis	0.000112	0.000398	CcSEcCtD
Letrozole—Dyspnoea—Triamcinolone—psoriasis	0.000111	0.000396	CcSEcCtD
Letrozole—Nervous system disorder—Betamethasone—psoriasis	0.000111	0.000395	CcSEcCtD
Letrozole—Nervous system disorder—Dexamethasone—psoriasis	0.000111	0.000395	CcSEcCtD
Letrozole—Tachycardia—Dexamethasone—psoriasis	0.000111	0.000393	CcSEcCtD
Letrozole—Tachycardia—Betamethasone—psoriasis	0.000111	0.000393	CcSEcCtD
Letrozole—Angioedema—Prednisone—psoriasis	0.00011	0.000393	CcSEcCtD
Letrozole—Dyspepsia—Triamcinolone—psoriasis	0.00011	0.000391	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—psoriasis	0.00011	0.00039	CcSEcCtD
Letrozole—Nausea—Mycophenolic acid—psoriasis	0.000109	0.00039	CcSEcCtD
Letrozole—Hyperhidrosis—Betamethasone—psoriasis	0.000109	0.00039	CcSEcCtD
Letrozole—Hyperhidrosis—Dexamethasone—psoriasis	0.000109	0.00039	CcSEcCtD
Letrozole—Feeling abnormal—Hydrocortisone—psoriasis	0.000109	0.000389	CcSEcCtD
Letrozole—Malaise—Prednisone—psoriasis	0.000109	0.000388	CcSEcCtD
Letrozole—Vertigo—Prednisone—psoriasis	0.000109	0.000386	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—psoriasis	0.000108	0.000386	CcSEcCtD
Letrozole—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000108	0.000386	CcSEcCtD
Letrozole—Anorexia—Betamethasone—psoriasis	0.000108	0.000384	CcSEcCtD
Letrozole—Anorexia—Dexamethasone—psoriasis	0.000108	0.000384	CcSEcCtD
Letrozole—Urticaria—Prednisolone—psoriasis	0.000108	0.000384	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—psoriasis	0.000108	0.000383	CcSEcCtD
Letrozole—Fatigue—Triamcinolone—psoriasis	0.000108	0.000383	CcSEcCtD
Letrozole—Asthenia—Cyclosporine—psoriasis	0.000107	0.000381	CcSEcCtD
Letrozole—Pain—Triamcinolone—psoriasis	0.000107	0.00038	CcSEcCtD
Letrozole—Pruritus—Cyclosporine—psoriasis	0.000106	0.000376	CcSEcCtD
Letrozole—Urticaria—Hydrocortisone—psoriasis	0.000105	0.000375	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—psoriasis	0.000105	0.000375	CcSEcCtD
Letrozole—Abdominal pain—Hydrocortisone—psoriasis	0.000105	0.000373	CcSEcCtD
Letrozole—Body temperature increased—Hydrocortisone—psoriasis	0.000105	0.000373	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—psoriasis	0.000105	0.000372	CcSEcCtD
Letrozole—Asthenia—Mycophenolate mofetil—psoriasis	0.000104	0.000372	CcSEcCtD
Letrozole—Hypertension—Prednisone—psoriasis	0.000104	0.000371	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000103	0.000367	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000103	0.000367	CcSEcCtD
Letrozole—Pruritus—Mycophenolate mofetil—psoriasis	0.000103	0.000366	CcSEcCtD
Letrozole—Myalgia—Prednisone—psoriasis	0.000103	0.000366	CcSEcCtD
Letrozole—Arthralgia—Prednisone—psoriasis	0.000103	0.000366	CcSEcCtD
Letrozole—Feeling abnormal—Triamcinolone—psoriasis	0.000103	0.000366	CcSEcCtD
Letrozole—Anxiety—Prednisone—psoriasis	0.000103	0.000365	CcSEcCtD
Letrozole—Alopecia—Methotrexate—psoriasis	0.000102	0.000365	CcSEcCtD
Letrozole—Insomnia—Dexamethasone—psoriasis	0.000102	0.000365	CcSEcCtD
Letrozole—Insomnia—Betamethasone—psoriasis	0.000102	0.000365	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000102	0.000364	CcSEcCtD
Letrozole—Diarrhoea—Cyclosporine—psoriasis	0.000102	0.000363	CcSEcCtD
Letrozole—Paraesthesia—Dexamethasone—psoriasis	0.000102	0.000362	CcSEcCtD
Letrozole—Paraesthesia—Betamethasone—psoriasis	0.000102	0.000362	CcSEcCtD
Letrozole—Discomfort—Prednisone—psoriasis	0.000102	0.000362	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—psoriasis	0.000102	0.000362	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—psoriasis	0.000101	0.000359	CcSEcCtD
Letrozole—Dyspepsia—Dexamethasone—psoriasis	9.97e-05	0.000355	CcSEcCtD
Letrozole—Dyspepsia—Betamethasone—psoriasis	9.97e-05	0.000355	CcSEcCtD
Letrozole—Diarrhoea—Mycophenolate mofetil—psoriasis	9.95e-05	0.000354	CcSEcCtD
Letrozole—Urticaria—Triamcinolone—psoriasis	9.91e-05	0.000353	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—psoriasis	9.89e-05	0.000352	CcSEcCtD
Letrozole—Body temperature increased—Triamcinolone—psoriasis	9.86e-05	0.000351	CcSEcCtD
Letrozole—Dizziness—Cyclosporine—psoriasis	9.86e-05	0.000351	CcSEcCtD
Letrozole—Oedema—Prednisone—psoriasis	9.86e-05	0.000351	CcSEcCtD
Letrozole—Anaphylactic shock—Prednisone—psoriasis	9.86e-05	0.000351	CcSEcCtD
Letrozole—Decreased appetite—Betamethasone—psoriasis	9.84e-05	0.00035	CcSEcCtD
Letrozole—Decreased appetite—Dexamethasone—psoriasis	9.84e-05	0.00035	CcSEcCtD
Letrozole—Infection—Prednisone—psoriasis	9.8e-05	0.000349	CcSEcCtD
Letrozole—CYP2A6—Xenobiotics—CYP2S1—psoriasis	9.78e-05	0.11	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Betamethasone—psoriasis	9.78e-05	0.000348	CcSEcCtD
Letrozole—Gastrointestinal disorder—Dexamethasone—psoriasis	9.78e-05	0.000348	CcSEcCtD
Letrozole—Back pain—Methotrexate—psoriasis	9.77e-05	0.000348	CcSEcCtD
Letrozole—Fatigue—Dexamethasone—psoriasis	9.76e-05	0.000348	CcSEcCtD
Letrozole—Fatigue—Betamethasone—psoriasis	9.76e-05	0.000348	CcSEcCtD
Letrozole—Pain—Betamethasone—psoriasis	9.68e-05	0.000345	CcSEcCtD
Letrozole—Pain—Dexamethasone—psoriasis	9.68e-05	0.000345	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—psoriasis	9.67e-05	0.000344	CcSEcCtD
Letrozole—Tachycardia—Prednisone—psoriasis	9.62e-05	0.000343	CcSEcCtD
Letrozole—Dizziness—Mycophenolate mofetil—psoriasis	9.62e-05	0.000342	CcSEcCtD
Letrozole—Skin disorder—Prednisone—psoriasis	9.58e-05	0.000341	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—psoriasis	9.53e-05	0.000339	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—psoriasis	9.52e-05	0.000339	CcSEcCtD
Letrozole—Asthenia—Hydrocortisone—psoriasis	9.51e-05	0.000339	CcSEcCtD
Letrozole—Vomiting—Cyclosporine—psoriasis	9.48e-05	0.000338	CcSEcCtD
Letrozole—Rash—Cyclosporine—psoriasis	9.4e-05	0.000335	CcSEcCtD
Letrozole—Anorexia—Prednisone—psoriasis	9.4e-05	0.000335	CcSEcCtD
Letrozole—Dermatitis—Cyclosporine—psoriasis	9.39e-05	0.000334	CcSEcCtD
Letrozole—Pruritus—Hydrocortisone—psoriasis	9.38e-05	0.000334	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—psoriasis	9.37e-05	0.000334	CcSEcCtD
Letrozole—Headache—Cyclosporine—psoriasis	9.34e-05	0.000333	CcSEcCtD
Letrozole—Feeling abnormal—Dexamethasone—psoriasis	9.33e-05	0.000332	CcSEcCtD
Letrozole—Feeling abnormal—Betamethasone—psoriasis	9.33e-05	0.000332	CcSEcCtD
Letrozole—Gastrointestinal pain—Dexamethasone—psoriasis	9.26e-05	0.00033	CcSEcCtD
Letrozole—Gastrointestinal pain—Betamethasone—psoriasis	9.26e-05	0.00033	CcSEcCtD
Letrozole—Vomiting—Mycophenolate mofetil—psoriasis	9.25e-05	0.000329	CcSEcCtD
Letrozole—Rash—Mycophenolate mofetil—psoriasis	9.17e-05	0.000327	CcSEcCtD
Letrozole—Dermatitis—Mycophenolate mofetil—psoriasis	9.16e-05	0.000326	CcSEcCtD
Letrozole—Headache—Mycophenolate mofetil—psoriasis	9.11e-05	0.000324	CcSEcCtD
Letrozole—Malaise—Methotrexate—psoriasis	9.11e-05	0.000324	CcSEcCtD
Letrozole—Vertigo—Methotrexate—psoriasis	9.07e-05	0.000323	CcSEcCtD
Letrozole—Diarrhoea—Hydrocortisone—psoriasis	9.07e-05	0.000323	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—psoriasis	9.04e-05	0.000322	CcSEcCtD
Letrozole—Urticaria—Dexamethasone—psoriasis	8.99e-05	0.00032	CcSEcCtD
Letrozole—Urticaria—Betamethasone—psoriasis	8.99e-05	0.00032	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Prednisone—psoriasis	8.98e-05	0.00032	CcSEcCtD
Letrozole—Dizziness—Prednisolone—psoriasis	8.97e-05	0.000319	CcSEcCtD
Letrozole—Asthenia—Triamcinolone—psoriasis	8.95e-05	0.000319	CcSEcCtD
Letrozole—Abdominal pain—Dexamethasone—psoriasis	8.95e-05	0.000319	CcSEcCtD
Letrozole—Body temperature increased—Dexamethasone—psoriasis	8.95e-05	0.000319	CcSEcCtD
Letrozole—Body temperature increased—Betamethasone—psoriasis	8.95e-05	0.000319	CcSEcCtD
Letrozole—Abdominal pain—Betamethasone—psoriasis	8.95e-05	0.000319	CcSEcCtD
Letrozole—Insomnia—Prednisone—psoriasis	8.92e-05	0.000317	CcSEcCtD
Letrozole—Nausea—Cyclosporine—psoriasis	8.86e-05	0.000315	CcSEcCtD
Letrozole—Paraesthesia—Prednisone—psoriasis	8.85e-05	0.000315	CcSEcCtD
Letrozole—Pruritus—Triamcinolone—psoriasis	8.83e-05	0.000314	CcSEcCtD
Letrozole—Cough—Methotrexate—psoriasis	8.81e-05	0.000314	CcSEcCtD
Letrozole—Dizziness—Hydrocortisone—psoriasis	8.76e-05	0.000312	CcSEcCtD
Letrozole—Dyspepsia—Prednisone—psoriasis	8.68e-05	0.000309	CcSEcCtD
Letrozole—Nausea—Mycophenolate mofetil—psoriasis	8.64e-05	0.000308	CcSEcCtD
Letrozole—Myalgia—Methotrexate—psoriasis	8.6e-05	0.000306	CcSEcCtD
Letrozole—Chest pain—Methotrexate—psoriasis	8.6e-05	0.000306	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—psoriasis	8.6e-05	0.000306	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—psoriasis	8.57e-05	0.000305	CcSEcCtD
Letrozole—Rash—Prednisolone—psoriasis	8.56e-05	0.000305	CcSEcCtD
Letrozole—Dermatitis—Prednisolone—psoriasis	8.55e-05	0.000304	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	8.54e-05	0.000304	CcSEcCtD
Letrozole—Fatigue—Prednisone—psoriasis	8.5e-05	0.000303	CcSEcCtD
Letrozole—Headache—Prednisolone—psoriasis	8.5e-05	0.000303	CcSEcCtD
Letrozole—Discomfort—Methotrexate—psoriasis	8.49e-05	0.000302	CcSEcCtD
Letrozole—Constipation—Prednisone—psoriasis	8.43e-05	0.0003	CcSEcCtD
Letrozole—Vomiting—Hydrocortisone—psoriasis	8.43e-05	0.0003	CcSEcCtD
Letrozole—Rash—Hydrocortisone—psoriasis	8.36e-05	0.000297	CcSEcCtD
Letrozole—Dermatitis—Hydrocortisone—psoriasis	8.35e-05	0.000297	CcSEcCtD
Letrozole—Headache—Hydrocortisone—psoriasis	8.3e-05	0.000296	CcSEcCtD
Letrozole—Dizziness—Triamcinolone—psoriasis	8.25e-05	0.000294	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—psoriasis	8.24e-05	0.000293	CcSEcCtD
Letrozole—Infection—Methotrexate—psoriasis	8.19e-05	0.000291	CcSEcCtD
Letrozole—Feeling abnormal—Prednisone—psoriasis	8.13e-05	0.000289	CcSEcCtD
Letrozole—Asthenia—Betamethasone—psoriasis	8.12e-05	0.000289	CcSEcCtD
Letrozole—Asthenia—Dexamethasone—psoriasis	8.12e-05	0.000289	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—psoriasis	8.08e-05	0.000288	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—psoriasis	8.06e-05	0.000287	CcSEcCtD
Letrozole—Nausea—Prednisolone—psoriasis	8.06e-05	0.000287	CcSEcCtD
Letrozole—Pruritus—Betamethasone—psoriasis	8.01e-05	0.000285	CcSEcCtD
Letrozole—Pruritus—Dexamethasone—psoriasis	8.01e-05	0.000285	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—psoriasis	8e-05	0.000285	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—psoriasis	7.97e-05	0.000284	CcSEcCtD
Letrozole—Vomiting—Triamcinolone—psoriasis	7.93e-05	0.000282	CcSEcCtD
Letrozole—Nausea—Hydrocortisone—psoriasis	7.87e-05	0.00028	CcSEcCtD
Letrozole—Rash—Triamcinolone—psoriasis	7.87e-05	0.00028	CcSEcCtD
Letrozole—Dermatitis—Triamcinolone—psoriasis	7.86e-05	0.00028	CcSEcCtD
Letrozole—Anorexia—Methotrexate—psoriasis	7.86e-05	0.00028	CcSEcCtD
Letrozole—Urticaria—Prednisone—psoriasis	7.83e-05	0.000279	CcSEcCtD
Letrozole—Headache—Triamcinolone—psoriasis	7.82e-05	0.000278	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—psoriasis	7.79e-05	0.000277	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—psoriasis	7.79e-05	0.000277	CcSEcCtD
Letrozole—Diarrhoea—Betamethasone—psoriasis	7.75e-05	0.000276	CcSEcCtD
Letrozole—Diarrhoea—Dexamethasone—psoriasis	7.75e-05	0.000276	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—psoriasis	7.51e-05	0.000267	CcSEcCtD
Letrozole—Dizziness—Dexamethasone—psoriasis	7.49e-05	0.000267	CcSEcCtD
Letrozole—Dizziness—Betamethasone—psoriasis	7.49e-05	0.000267	CcSEcCtD
Letrozole—Insomnia—Methotrexate—psoriasis	7.45e-05	0.000265	CcSEcCtD
Letrozole—Nausea—Triamcinolone—psoriasis	7.41e-05	0.000264	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—psoriasis	7.4e-05	0.000263	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—psoriasis	7.35e-05	0.000262	CcSEcCtD
Letrozole—Somnolence—Methotrexate—psoriasis	7.33e-05	0.000261	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—psoriasis	7.25e-05	0.000258	CcSEcCtD
Letrozole—Vomiting—Betamethasone—psoriasis	7.2e-05	0.000256	CcSEcCtD
Letrozole—Vomiting—Dexamethasone—psoriasis	7.2e-05	0.000256	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—psoriasis	7.16e-05	0.000255	CcSEcCtD
Letrozole—Rash—Dexamethasone—psoriasis	7.14e-05	0.000254	CcSEcCtD
Letrozole—Rash—Betamethasone—psoriasis	7.14e-05	0.000254	CcSEcCtD
Letrozole—Dermatitis—Betamethasone—psoriasis	7.13e-05	0.000254	CcSEcCtD
Letrozole—Dermatitis—Dexamethasone—psoriasis	7.13e-05	0.000254	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—psoriasis	7.11e-05	0.000253	CcSEcCtD
Letrozole—Fatigue—Methotrexate—psoriasis	7.1e-05	0.000253	CcSEcCtD
Letrozole—Headache—Betamethasone—psoriasis	7.09e-05	0.000253	CcSEcCtD
Letrozole—Headache—Dexamethasone—psoriasis	7.09e-05	0.000253	CcSEcCtD
Letrozole—Asthenia—Prednisone—psoriasis	7.07e-05	0.000252	CcSEcCtD
Letrozole—Pain—Methotrexate—psoriasis	7.05e-05	0.000251	CcSEcCtD
Letrozole—Pruritus—Prednisone—psoriasis	6.98e-05	0.000248	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—psoriasis	6.79e-05	0.000242	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—psoriasis	6.75e-05	0.00024	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—psoriasis	6.74e-05	0.00024	CcSEcCtD
Letrozole—Nausea—Dexamethasone—psoriasis	6.73e-05	0.000239	CcSEcCtD
Letrozole—Nausea—Betamethasone—psoriasis	6.73e-05	0.000239	CcSEcCtD
Letrozole—Urticaria—Methotrexate—psoriasis	6.55e-05	0.000233	CcSEcCtD
Letrozole—Dizziness—Prednisone—psoriasis	6.52e-05	0.000232	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—psoriasis	6.51e-05	0.000232	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—psoriasis	6.51e-05	0.000232	CcSEcCtD
Letrozole—Vomiting—Prednisone—psoriasis	6.27e-05	0.000223	CcSEcCtD
Letrozole—Rash—Prednisone—psoriasis	6.22e-05	0.000221	CcSEcCtD
Letrozole—Dermatitis—Prednisone—psoriasis	6.21e-05	0.000221	CcSEcCtD
Letrozole—Headache—Prednisone—psoriasis	6.18e-05	0.00022	CcSEcCtD
Letrozole—Asthenia—Methotrexate—psoriasis	5.91e-05	0.00021	CcSEcCtD
Letrozole—Nausea—Prednisone—psoriasis	5.86e-05	0.000209	CcSEcCtD
Letrozole—Pruritus—Methotrexate—psoriasis	5.83e-05	0.000208	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—psoriasis	5.64e-05	0.000201	CcSEcCtD
Letrozole—Dizziness—Methotrexate—psoriasis	5.45e-05	0.000194	CcSEcCtD
Letrozole—Vomiting—Methotrexate—psoriasis	5.24e-05	0.000187	CcSEcCtD
Letrozole—Rash—Methotrexate—psoriasis	5.2e-05	0.000185	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—psoriasis	5.19e-05	0.000185	CcSEcCtD
Letrozole—Headache—Methotrexate—psoriasis	5.16e-05	0.000184	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.1e-05	0.0573	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.04e-05	0.0565	CbGpPWpGaD
Letrozole—Nausea—Methotrexate—psoriasis	4.89e-05	0.000174	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.14e-05	0.0464	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.06e-05	0.0456	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.01e-05	0.045	CbGpPWpGaD
Letrozole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	3.59e-05	0.0403	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.29e-05	0.037	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	2.54e-05	0.0286	CbGpPWpGaD
Letrozole—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	2.46e-05	0.0276	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP2S1—psoriasis	2.2e-05	0.0247	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	2.17e-05	0.0243	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CAT—psoriasis	1.9e-05	0.0213	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	1.85e-05	0.0208	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP2S1—psoriasis	1.75e-05	0.0196	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	1.69e-05	0.0189	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	1.62e-05	0.0182	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.49e-05	0.0167	CbGpPWpGaD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	1.47e-05	0.0165	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.47e-05	0.0165	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.21e-05	0.0136	CbGpPWpGaD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	1.19e-05	0.0134	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFA—psoriasis	9.74e-06	0.0109	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.84e-06	0.00768	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.41e-06	0.0072	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.33e-06	0.0071	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	6.24e-06	0.007	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.53e-06	0.00621	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.77e-06	0.00535	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NDUFA5—psoriasis	4.42e-06	0.00496	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.12e-06	0.00463	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2S1—psoriasis	3.76e-06	0.00422	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NDUFA5—psoriasis	3.52e-06	0.00395	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	3.52e-06	0.00395	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	3.39e-06	0.0038	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	3.07e-06	0.00345	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2S1—psoriasis	2.99e-06	0.00336	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	2.32e-06	0.00261	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.97e-06	0.00221	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CARM1—psoriasis	1.84e-06	0.00206	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.72e-06	0.00193	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CARM1—psoriasis	1.46e-06	0.00164	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NDUFA5—psoriasis	1.29e-06	0.00145	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAT—psoriasis	1.13e-06	0.00127	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2S1—psoriasis	1.1e-06	0.00123	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAT—psoriasis	8.99e-07	0.00101	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOE—psoriasis	8.77e-07	0.000985	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—psoriasis	7.64e-07	0.000858	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOE—psoriasis	6.98e-07	0.000784	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—psoriasis	6.08e-07	0.000683	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CARM1—psoriasis	5.36e-07	0.000601	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAT—psoriasis	3.29e-07	0.00037	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOE—psoriasis	2.56e-07	0.000287	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—psoriasis	2.23e-07	0.00025	CbGpPWpGaD
